Evergreen Talk Series: How can Safety and Tolerability of Linagliptin and Dapagliflozin benefit diverse T2DM population? MD Brand Connect25 March 2024 4:38 PM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Red light can reduce blood glucose levels, says study Dr. Kamal Kant Kohli15 March 2024 8:30 PM ISTThe researchers found that 670 nanometres (nm) of red light stimulated energy production within mitochondria, the tiny powerhouses within cells,...
Insights from "EVER-Vilda", Expert Perspective on Vildagliptin's Applicability in Indian T2DM Patients MDTV Bureau14 March 2024 2:45 AM ISTThe "EVER-Vilda" opinion paper is an Indian expert's evaluation of the efficacy and rationality of vildagliptin. It underscores vildagliptin's...
FDA Clears First Over-the-Counter Continuous Glucose Monitor Dr. Kamal Kant Kohli8 March 2024 6:00 AM ISTToday, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo...
Medical Bulletin 22/February/2024 Anshika Mishra22 Feb 2024 3:00 PM ISTHere are the top medical news highlights for the day:Research discovers microplastics in every human placenta In a study published on February 17...
Red light has the potential to decrease blood glucose levels, study suggests Anshika Mishra22 Feb 2024 3:45 AM ISTA study published in the Journal of Biophotonics indicates that red light has been shown to decrease blood glucose levels by 27.7% after glucose...
Evergreen Talk Series: Combination of Linagliptin and Dapagliflozin in T2DM with multiple episodes of hypoglycemia MDTV Bureau21 Feb 2024 9:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Evergreen Talk Series: Use of SGLT2i and DPP4i combination in T2DM patients with a history of Genitourinary Tract Infections MD Brand Connect1 Feb 2024 10:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Evergreen Talk Series: Position paper published in JAPI indicated that Linagliptin is simplifying T2DM management in a Wide Range of Patients MDTV Bureau23 Jan 2024 11:30 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani, an...
Evergreen Talk Series: Clinical Considerations for Linagliptin and its combinations with Metformin, Dapagliflozin MD Brand Connect2 Jan 2024 11:00 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr Sameer I. Dani,...
Evergreen Talk Series: Linagliptin and Dapagliflozin combination for T2DM with Cardiovascular risk or established ASCVD MD Brand Connect21 Dec 2023 11:45 AM ISTPresenting the Evergreen Talk Series featuring Dr. Brij Mohan Makkar, a Senior Diabetologist and Obesity Specialist from Delhi, Dr. Sameer I. Dani,...
RPG Dietary fibre may help enhance satiety and reduce postprandial glucose Niveditha Subramani4 Dec 2023 11:30 AM ISTDietary fibre is made up of the indigestible parts or compounds of plants, which pass relatively unchanged through our stomach and intestines. Fibre...
